MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Zimmer Biomet Holdings Book Value 2011-2026 | ZBH
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value Zimmer Biomet Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.5 B | 12.5 B | 12 B | 12.7 B | 12.2 M | 12.4 B | 11.3 B | 11.7 B | 9.67 B | 9.89 B | 6.52 B | 6.3 B | 5.87 B | 5.51 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 12.7 B | 12.2 M | 9.2 B |
Quarterly Book Value Zimmer Biomet Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.8 B | 12.5 B | 12.4 B | 12.4 B | 12.7 B | 12.6 B | 12.5 B | 12.4 B | 12.2 B | 12 B | 12.3 B | - | 12 B | 12.7 B | 12.7 B | 12.6 B | 12.7 B | 12.2 B | 12.2 B | 12.2 B | 12.2 B | 12.4 B | 12.4 B | 12.4 B | 12.4 B | 11.3 B | 11.3 B | 11.3 B | 11.3 B | 11.7 B | 11.7 B | 11.7 B | 11.7 B | 9.67 B | 9.67 B | 9.67 B | 9.67 B | 9.89 B | 9.89 B | 9.89 B | 9.89 B | 6.55 B | 6.55 B | 6.52 B | 6.52 B | 6.31 B | 6.3 B | 6.3 B | 6.3 B | 5.87 B | 5.87 B | 5.87 B | 5.87 B | 5.51 B | 5.51 B | 5.51 B | 5.51 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 12.8 B | 5.51 B | 10.1 B |
Book Value of other stocks in the Medical devices industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Bruker Corporation
BRKR
|
1.82 B | $ 39.25 | -0.58 % | $ 5.85 K |  USA |
 |
Align Technology
ALGN
|
3.85 B | $ 185.94 | -0.32 % | $ 13.9 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
570 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
27.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
133 M | - | 37.08 % | $ 85.7 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
196 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
-879 K | - | -26.83 % | $ 2.62 M | USA |
 |
Conformis
CFMS
|
54.2 M | - | - | $ 16.4 M | USA |
 |
Avinger
AVGR
|
-6.2 M | - | -20.74 % | $ 369 K | USA |
 |
AdaptHealth Corp.
AHCO
|
1.53 B | $ 12.5 | -1.23 % | $ 1.69 B | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
272 M | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
25.5 M | - | -5.86 % | $ 30.6 M | USA |
 |
Cytosorbents Corporation
CTSO
|
5.9 M | $ 0.61 | 2.33 % | $ 38 M | USA |
 |
EDAP TMS S.A.
EDAP
|
40.9 M | $ 3.61 | 2.56 % | $ 135 M |  France |
 |
LENSAR
LNSR
|
-12.2 M | $ 5.88 | -5.92 % | $ 70.3 M | USA |
 |
Boston Scientific Corporation
BSX
|
43.7 B | $ 63.77 | -1.3 % | $ 94.4 B | USA |
 |
Apollo Endosurgery
APEN
|
32.6 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
249 M | - | 0.15 % | $ 844 M | USA |
 |
Eargo
EAR
|
101 M | - | - | $ 10.2 M | USA |
 |
ClearPoint Neuro
CLPT
|
28 M | $ 10.64 | 1.72 % | $ 301 M | USA |
 |
Dynatronics Corporation
DYNT
|
3.26 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
43.2 M | $ 25.35 | -1.4 % | $ 214 M | USA |
 |
Second Sight Medical Products
EYES
|
15.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
CryoLife, Inc.
CRY
|
58.1 M | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
6.23 M | - | 1.15 % | $ 34.5 M | USA |
 |
Sintx Technologies
SINT
|
2.93 M | $ 2.69 | -1.82 % | $ 7.46 M | USA |
 |
Soliton, Inc.
SOLY
|
243 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
2.61 B | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
2.81 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
229 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
30.4 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
52.2 M | - | - | $ 111 M |  Canada |
 |
Stryker Corporation
SYK
|
22.4 B | $ 337.01 | -1.24 % | $ 129 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
347 M | $ 16.96 | -4.99 % | $ 398 M | USA |
 |
Globus Medical
GMED
|
4.57 B | $ 93.16 | -1.47 % | $ 12.6 B | USA |
 |
Tactile Systems Technology
TCMD
|
219 M | $ 25.05 | -1.18 % | $ 573 M | USA |
 |
TELA Bio
TELA
|
6.31 M | $ 0.65 | -0.61 % | $ 30.5 M | USA |
 |
Helius Medical Technologies
HSDT
|
2.35 M | $ 1.96 | 1.03 % | $ 1.19 M | USA |
 |
Butterfly Network
BFLY
|
169 M | $ 5.45 | 12.14 % | $ 1.15 B | USA |
 |
Intersect ENT, Inc.
XENT
|
550 M | - | - | $ 955 M | USA |
 |
Tandem Diabetes Care
TNDM
|
155 M | $ 20.25 | -1.98 % | $ 1.38 B | USA |
 |
Inogen
INGN
|
192 M | $ 6.33 | 2.1 % | $ 168 M | USA |
 |
IRIDEX Corporation
IRIX
|
4.92 M | $ 1.03 | -0.93 % | $ 17.4 M | USA |
 |
BIOLASE
BIOL
|
1.96 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
111 M | $ 10.85 | -1.27 % | $ 389 M | USA |
 |
Inspire Medical Systems
INSP
|
781 M | $ 56.71 | 0.11 % | $ 1.67 B | USA |
 |
CONMED Corporation
CNMD
|
1.03 B | $ 38.23 | -3.07 % | $ 1.19 B | USA |
 |
LivaNova PLC
LIVN
|
1.2 B | $ 64.7 | -0.68 % | $ 3.53 B |  Britain |
 |
Integer Holdings Corporation
ITGR
|
1.75 B | $ 88.42 | 0.55 % | $ 3.07 B | USA |